Clinical Trials in Oberhausen, Germany
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients
First-line TreatmentBasal Cell Carcinoma (BCC)
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest34 enrolled7 locationsNCT06981325
Recruiting
Phase 2Phase 3
Therapy Optimisation for the Treatment of Hairy Cell Leukemia
Hairy Cell Leukemia
University of Giessen210 enrolled76 locationsNCT02131753